Related Experiment Videos
Pharmacologic interventions for reducing spasticity in cerebral palsy
Dilip R Patel1, Olufemi Soyode
1Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, Michigan 49008, USA. patel@kcms.msu.edu
Indian Journal of Pediatrics
|November 8, 2005
Summary
Cerebral palsy (CP) spasticity management requires careful consideration. Both non-pharmacologic and pharmacologic interventions are available to improve motor function in children with CP.
Area of Science:
- Neurology
- Pediatrics
- Rehabilitation Medicine
Background:
- Motor dysfunction, particularly spasticity, is a hallmark of cerebral palsy (CP).
- Spasticity, characterized by velocity-dependent resistance to passive movement, presents unique challenges in CP management.
- The impact of spasticity varies, potentially hindering or aiding motor abilities like posture and ambulation.
Purpose of the Study:
- To review non-pharmacologic and pharmacologic interventions for reducing spasticity in children with cerebral palsy.
- To highlight the importance of individualized treatment strategies based on spasticity's impact.
Main Methods:
- Review of non-pharmacologic interventions: physiotherapy, occupational therapy, adaptive equipment, orthopedic surgery, neurosurgery.
- Review of pharmacologic interventions: oral medications (baclofen, diazepam, dantrolene, tizanidine), intrathecal baclofen, and local injections (botulinum toxin, phenol, alcohol).
Main Results:
- Non-pharmacologic approaches offer diverse strategies for spasticity management.
- Pharmacologic options provide targeted treatments for spasticity reduction.
- Treatment decisions must balance potential benefits and drawbacks of each intervention.
Conclusions:
- Comprehensive management of spasticity in cerebral palsy involves a multidisciplinary approach.
- Tailoring interventions to individual patient needs is crucial for optimizing outcomes.
- Further research into the efficacy and comparative effectiveness of different spasticity treatments is warranted.